First oral drug for spinal cord injury improves movement in mice
An experimental oral drug given to mice after a spinal cord injury was effective at improving limb movement after the injury, a new study shows.
Neuroscience
Jan 08, 2013 |
5 / 5 (7) |
0
|
Novel anti-clotting drug more effective than Plavix in coronary procedures, study says
(Medical Xpress)—An experimental drug has been shown to be significantly more effective at preventing blood clots during coronary stenting procedures compared to the anti-clotting agent now typically used, according to ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
|
New drug overcomes resistance in patients with rare sarcoma
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report ...
Cancer
Nov 21, 2012 |
5 / 5 (1) |
0
|
Common food preservative may slow, even stop tumor growth
Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found.
Cancer
Oct 31, 2012 |
4.8 / 5 (6) |
0
|
Children taking steroids for asthma are slightly shorter than peers
Children who use inhaled steroid drugs for asthma end up slightly shorter at their full adult height than children who don't use the drugs, new results from a comprehensive asthma study show.
Immunology
Sep 03, 2012 |
5 / 5 (1) |
1
|
Gonorrhea resistant to all but one antibiotic: CDC
(HealthDay) -- With options shrinking to a single antibiotic that can fight resistant strains of gonorrhea, U.S. health authorities issued revised guidelines for treating the sexually transmitted bacteria ...
Diseases, Conditions, Syndromes
Aug 09, 2012 |
5 / 5 (1) |
1
|
US approves first pill to help prevent HIV
(AP) — The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS.
HIV & AIDS
Jul 16, 2012 |
4 / 5 (1) |
0
Birth control that uses combined hormones raises heart risk: study
(HealthDay) -- Sweeping new research comparing various forms of hormonal contraception -- including birth control pills, vaginal rings and skin patches -- suggests that the risk for heart attacks and strokes ...
Medications
Jun 13, 2012 |
not rated yet |
1
|
Study shows benefit of new maintenance therapy for multiple myeloma
Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. A medical procedure called ...
Cancer
May 11, 2012 |
5 / 5 (1) |
0
|
Certain birth control pills may carry higher blood clot risk: FDA
(HealthDay) -- U.S. health officials announced Tuesday that birth controls pills containing drospirenone -- a man-made version of the hormone progesterone -- may be associated with a higher risk of blood clots ...
Medications
Apr 10, 2012 |
5 / 5 (1) |
0
|
Dental plaque bacteria may trigger blood clots
Oral bacteria that escape into the bloodstream are able to cause blood clots and trigger life-threatening endocarditis. Further research could lead to new drugs to tackle infective heart disease, say scientists presenting ...
Cardiology
Mar 26, 2012 |
not rated yet |
0
|
New oral drug found to reduce relapses in multiple sclerosis patients
A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease.
Medications
Oct 06, 2011 |
5 / 5 (1) |
0
|
'Micro'-chemo and cancer pill combo tested in liver cancer patients
A combination of an oral drug, called sorafenib, and a method for injecting microbeads of chemotherapy directly into tumors has been proven safe for liver cancer patients and may improve outcomes for those who have these ...
Cancer
Sep 30, 2011 |
5 / 5 (3) |
0
|
PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations
In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced ...
Cancer
May 15, 2013 |
not rated yet |
0
Nearly 5 million asthmatics could benefit from antifungal therapy
An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.
Inflammatory disorders
May 08, 2013 |
not rated yet |
0
